Welcome to our dedicated page for Im Cannabis SEC filings (Ticker: IMCC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking IM Cannabis Corp’s cross-border disclosures can feel like deciphering two rulebooks at once—U.S. SEC regulations and the strict cannabis frameworks of Israel and Germany. Licenses, EU-GMP supply agreements, and biological asset valuations are scattered across hundreds of pages.
Stock Titan’s AI reads every new filing the moment it lands on EDGAR, then translates the legal jargon into clear takeaways. Whether you open the latest IM Cannabis quarterly earnings report 10-Q filing or an 8-K about a German distribution contract, you’ll see plain-language highlights, red-flag alerts, and side-by-side metrics. Need “IM Cannabis insider trading Form 4 transactions”? Our platform streams Form 4 insider transactions in real-time, flags unusual executive stock movements, and links them to the dates of material events. Annual deep dives are just as accessible—“IM Cannabis annual report 10-K simplified” appears alongside concise AI summaries of cultivation yields, segment revenue, and pending regulatory risks.
Investors use these insights to:
- Spot patterns in “IM Cannabis executive stock transactions Form 4” before new product launches.
- Compare Israeli pharmacy sales across quarters with our “IM Cannabis earnings report filing analysis.”
- Quickly review “IM Cannabis proxy statement executive compensation” to evaluate incentive alignment.
From “IM Cannabis SEC filings explained simply” to “IM Cannabis 8-K material events explained,” Stock Titan consolidates every document type—10-Q, 10-K, S-1, 6-K, and more—into one continuously updated dashboard. Understanding IM Cannabis SEC documents with AI now takes minutes, not hours.
IM Cannabis Corp. announced a CFO transition. Chief Financial Officer Uri Birenberg will step down for personal reasons and is expected to continue in the role until January 5, 2026, or an earlier date determined by the company. The company stated his decision was not due to any disagreement regarding operations, policies, or practices.
This 6-K (excluding designated press release paragraphs) is incorporated by reference into IM Cannabis’ Form F-3 registration statements, File Nos. 333-289571 and 333-288346.
IM Cannabis Corp. (IMCC) furnished a Form 6-K announcing a Notice of a Special Meeting of Security Holders to be held on December 29, 2025.
The notice is attached as Exhibit 99.1. This submission is incorporated by reference into the company’s Form F-3 registration statements (File Nos. 333-289571 and 333-288346).
IM Cannabis Corp. filed a Form 6-K reporting that it issued a press release dated October 23, 2025. The release states the company signed a non-binding term sheet to acquire a 60% stake in Innovative Quantum Computing Bio Data.
This filing signals a potential transaction at the term-sheet stage; terms and closing details are not included in the provided excerpt.
IM Cannabis Corp. furnished a Current Report on Form 6-K that includes a press release dated
IM Cannabis Corp. amended certain common share purchase warrants issued in its 2024 private placement by reducing the exercise price from C$4.32 to C$3.43 and extending the expiration date from November 12, 2026 to July 31, 2030. The warrants were originally exercisable upon issuance and, except for the exercise price and expiration, all other terms remain unchanged.
The amendments increase the timeframe and the lower threshold at which warrant holders may convert into common shares, which could raise the likelihood of exercise and therefore the potential for dilution if exercised. The Form of Warrant, the Form of Amendment and a press release are included as exhibits and the report is incorporated by reference into the company’s Form F-3 registration statements.
IM Cannabis Corp. submitted a Form 6-K reporting for the month of August 2025 and furnished several attachments dated August 12, 2025. The report includes a news release, interim consolidated financial statements for the three- and six-month periods ended June 30, 2025, a management's discussion and analysis (MD&A) for those periods, and CEO and CFO certifications of the interim filings. The form is signed by Oren Shuster as Chief Executive Officer and Director. The company indicates it files annual reports on Form 20-F.
FAQ
What is the current stock price of Im Cannabis (IMCC)?
What is the market cap of Im Cannabis (IMCC)?
